News

SEARCH FIRM NEWS

publication January 18, 2021

USPTO issues new & revised guidance on patent eligibility under 35 USC 101. USA – December 19 2014, Lexology.

USPTO issues new & revised guidance on patent eligibility under 35 USC 101. USA - December 19 2014, Lexology.

publication January 18, 2021

Teva v. Sandoz: the new standard of review in claim construction. USA – January 31 2015, Lexology.

Teva v. Sandoz: the new standard of review in claim construction. USA - January 31 2015, Lexology.

publication January 18, 2021

FeSSIFFaSSIF dissolution: if you understand what is written above you should read this article. USA – December 8 2014, Lexology.

FeSSIFFaSSIF dissolution: if you understand what is written above you should read this article. USA - December 8 2014, Lexology.

publication January 18, 2021

Phase III biosimilar clinical trial & infringement threat does not create justiciable case or controversy: biosimilars will require the patent dance. USA – December 15 2014, Lexology.

Phase III biosimilar clinical trial & infringement threat does not create justiciable case or controversy: biosimilars will require the patent dance. USA - December 15 2014, Lexology.

publication January 18, 2021

Promega v. Life Technologies: a higher enablement standard for “comprising” not within the preamble of the claim. USA – January 16 2015, Lexology.

Promega v. Life Technologies: a higher enablement standard for “comprising” not within the preamble of the claim. USA - January 16 2015, Lexology.

news January 15, 2021

FDA immediately exempts 7 medical devices from the 510(k) requirement and proposes to exempt an additional 83 more.

The COVID-19 public health emergency brought about a sudden and unexpected need for personal protective equipment and other medical devices. In response, the Food and Drug Administration (FDA) issued a number of guidance documents that, among other things, waived the premarket notification (510(k)) requirement for the lawful distribution of these devices during the public health […]

news November 5, 2020

Evan Phelps To Present Webinar On Breakthrough Medical Devices

Monday, Nov. 16, 2020 • 1:30 p.m. – 3:00 p.m. EST In the past, it’s been difficult to get marketing authorization from the FDA for novel medical device technologies — and even if those authorizations were made, it could take years for a Centers for Medicare and Medicaid Services (CMS) coverage decision. Not anymore. With […]

news September 16, 2020

Accomplished Litigator George Spatz Joins Amin Talati; Will Lead Ligation Practice

Leading regulatory and intellectual property law firm Amin Talati Wasserman LLP today announced that prominent litigation attorney George Spatz has joined the firm as a partner and is leading the firm’s litigation practice group. CHICAGO (PRWEB) SEPTEMBER 16, 2020 George Spatz has nearly two decades of experience litigating cases in federal and state court, alternative dispute resolution […]

What's Now

Amin Talati Adds Medical Device Patent Practice With Addition of Partner in Chicago

Leading regulatory and intellectual property law firm Amin Talati Wasserman LLP today announced that prominent medical technology patent attorney Peter Paredes has joined the firm as a partner in Chicago. CHICAGO (PRWEB) JANUARY 21, 2021 Peter MORE >

see all news >